Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1995-06-27
1999-02-23
Loring, Susan A.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241581, 53038823, 5305873, A61K 39395, C07K 1624, C07K 1600
Patent
active
058740805
ABSTRACT:
Methods are provided for the treatment of asthma with anti-IL-8 monoclonal antibodies.
REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5290550 (1994-03-01), Fisher et al.
Boylan et al., "Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits" J. Clin. Invest. 89:1257-1267 (1992).
Boylan et al., "Interleukin-8 is a major component of pleural liquid chemotactic activity in a rabbit model of endotoxin pleurisy" Amer. J. Physiol. 267(2):L137-L144 (1994).
Broaddus et al., "Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema" Amer. Rev. Resp. Disease 146:825-830 (1992).
Stockley, Robert A., "Role of Inflammation in Respiratory Tract Infections" Amer. J. Med. 99(Supp. 6B) :8S-13S (1995).
Bellini et al., "Respiratory pathophysiologic responses: Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytes" J. Allergy Clin. Immunol. 92(3):412-424 (1993).
Bittleman & Casale, "Allergic models and cytokines" Am. J. Respir. Crit. Care Med. 150(5):S72-S76 (1994).
Cacalano et al., "Neutrophil and B cell expansion in mice that lack the murine IL-8 receeptor homolog" Science 265:682-684 (Jul. 1994).
Casini-Raggi et al., "A specfic monoclonal antibody (MoAb) against interleukin-8 (IL-8) suppresses inflammation in rabbit immune colitis" Immunology, Microbiology & Inflammatory Disorders (abstract only) 106(4 Supp.) :A661 (Apr. 1994).
Corrigan et al., "Cultured peripheral blood mononuclear cells derived from patients with acute severe asthma (Status Asthaticus) spontaneously elaborate a neutrophil chemotactic activity distinct from interleukin-8.sup.1-3 " Am. Rev. Respir. Dis. 143(3) :538-544.
Cross et al., "Choice of Bacteria in Animal Models of Sepsis" Inf. & Immunity 61(7) :2741-2747 (Jul. 1993).
Dubois et al., "IL-4-induced migration of eosinophils in allergic inflammation" Annals New York Acad. Science 725:268-273 (1993).
Erger et al., "Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium" Am. J. Physiol. 268(1):L117-L122 (1995).
Fahy, J.V. et al., "Respiratory pathophysiologic responses: prominant neutrophilic inflammation in sputum from subjects with asthma exacerbation" J. Allergy & Clincal Immunol. 95(4):843-852 (1995).
Fisher, R.H. et al., "Interleukin-8 (IL-8) reverses hyperreactivity and blocks allergen-induced late phase reactions" J. Allergy Clin. Immunol. (abstract only) 89(1 of 2):p. 165, abs 81 (1992).
Hallsworth et al., "Selective enhancement of GM-CSF, TNF-.alpha., IL-1.beta. and IL-8 production by monocytes and macrophages of asthmatic subjects" Eur. Respir. J. 7(6):1096-1102 (1994).
Harris et al., "Therapeutic antibodies--the coming of age" TIBECH 11:42-44 (Feb. 1993).
Hebert et al., "Interleukin-8: A Review" Cancer Investigation 11(6):743-750 (1993).
Hood et al., "IL-8 levels are increased in the plasma of atopic non-asthmatic, but not atopic subjects" Eur. Respir. J. 7(Supp. 8)Lp. 434s, abs 1966 (1994).
in't Veen et al., "Interleukin-8(IL-8) and monocyte chemoattractant protein-1 (MCP-1) are elevated in induced sputum in asthma" Eur. Respir. J. 7(Suppl 18) :p. 19S, abs 0170 (1994).
Kameyoshi et al., "Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils" Journal of Experimental Medicine 176(2):587-592 (1992 1992).
Ko et al., "A sensitive enzyme-linked immunosorbent assay for human interleukin-8" J. Immunol. Methods 149:227-235 (1992).
Marini et al., "Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma" J. Allergy Clin. Immuno. 89(5):1001-1009 (1992).
Mulligan et al., "Inhibition of Lung Inflammatory Reactions in Rats by an Anti-Human IL-8 Antibody" 150(12):5585-5595 (Jun. 15, 1993).
Sartor, R. Balfour, "Animal Models of Intestinal Inflammation--Relevance to Inflammatory Bowel Disease" Inflammatory Bowel Disease (Chapter 18), MacDermott et al., New York: Elsevier pp. 337-353 (1992).
Sekido et al., "Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8" Nature 365:654-657 (Oct. 14, 1993).
Smith, Diana et al., "Interleukin-8--A mediator of inflammatory lung disease?" Advances in Experimental Medicine and Biology 305:119-126 (1991).
St. John et al., "ImmunologicTherapy for ARDS, Septic Shock, and Multiple-Organ Failure" Chest 103:932-943 (1993).
Sticherling et al., "Immunohistochemical studies on NAP-1/IL-8 in contact eczema and atopic dermatitis" Arch. Dermatol. Res. 284:82-85 (1992).
Sticherling et al., "Production and Characterization of Monoclonal Antibodies Against the Novel Neutrophil Activating Peptide NAP/IL-8" J. Immunol. 1435):1628-1634 (Sep. 1, 1989).
Teran, L.M. et al., "Neutrophil and eosinophil chemotaxins in asthma"Quarterly Journal of Medicine 86:761-769 (1993).
Virchow, Jr. et al., "T cells and cytokines in bronchoalveolar lavage fluid after segmental allerge n provocation in atopic asthma" Am. J. Respiratory and Critical Care Medicine 151(4):960-968 (1995).
Wada et al., "Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis" Journal of Experimental Medicine 180:1135-1140 (1994).
Waldman, Thomas A., "Monoclonal Antibodies in Diagnosis and Therapy" Science 252:1657-1662 (Jun. 21, 1991).
Walker, C. et al., "Activated T cells and cytokines in brochoalveolar lavages from patients with vraious lung diseases associated with eosinophilia" Am. J. Respir. Crit. Care Med. 150(4):1038-1048 (1994).
Wang, J.H. et al., "Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinphils in the bronchial epithelium of patients with mild asthma" J. Allergy Clin. Immunol. 94(6 Pt. 1):1025-1034 (1994).
Warringa et al., "Allergens, IgE, mediators, inflammatory mechanisms: Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma" J. Allergy Clin. Immunol. 916):1198-1205 (1993).
Warringa et al., "Modulation of eosinophil chemotaxis by interleukin-5" Am. J. respir. Cell Mol. Biol. 7(6):631-636 (1992).
Xiu, Q et al., "Bronchial hyperresponsiveness and airway neutrophil accumulation induced by intereukin-8 and the effect of the thromboxane A.sub.2 antagonist S-1452 in guinea-pigs" Clin. Exp. Allergy 25(1):51-59 (1995).
Yousefi et al., "IL-8 is expressed by human peripheral blood eosinophils" J. Immunol. 154(10):5481-5490 (1995).
Hebert Caroline A.
Kabakoff Rhona C.
Moore Mark W.
Genentech Inc.
Loring Susan A.
Love Richard B.
LandOfFree
Anti-IL-8 monoclonal antibodies for treatment of asthma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-IL-8 monoclonal antibodies for treatment of asthma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-IL-8 monoclonal antibodies for treatment of asthma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-304175